Clinical trial
Prognostic Role of the Human Metapneumovirus (hMPV) Compared to Other Common Respiratory Viruses in Older Inpatients: a Cohort Study
NCT07813481 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Role of the Human Metapneumovirus (hMPV) Compared to Other Common Respiratory Viruses in Older Inpatients: a Cohort Study
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- October 31, 2030
- Enrollment
- 1,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
adenovirus, coronavirus, human metapneumovirus (hmpv), influenza viruses, parainfluenza virus (piv), respiratory syncytial virus (rsv), rhinovirus, severe acute respiratory syndrome coronavirus 2